Latest News

Aerospace and defense company BWX (NYSE:BWXT) reported Q1 CY2025 results topping the market’s revenue expectations, with sales up 13% year on year to $682.3 million. On the other hand, the company’s full-year revenue guidance of $3 billion at the midpoint came in 0.9% below analysts’ estimates. Its non-GAAP profit of $0.91 per share was 19% above analysts’ consensus estimates.

Maritime transportation company Matson (NYSE:MATX) missed Wall Street’s revenue expectations in Q1 CY2025, but sales rose 8.3% year on year to $782 million. Its GAAP profit of $2.18 per share was 3.8% below analysts’ consensus estimates.

Medical device company Artivion (NYSE:AORT) reported Q1 CY2025 results beating Wall Street’s revenue expectations, with sales up 1.6% year on year to $98.98 million. The company’s full-year revenue guidance of $429 million at the midpoint came in 1.2% above analysts’ estimates. Its non-GAAP profit of $0.06 per share was $0.02 above analysts’ consensus estimates.

Toy manufacturing and entertainment company (NASDAQ:MAT) announced better-than-expected revenue in Q1 CY2025, with sales up 2.1% year on year to $826.6 million. Its non-GAAP loss of $0.03 per share was 70.4% above analysts’ consensus estimates.

Biopharma company Corcept Therapeutics (NASDAQ:CORT) missed Wall Street’s revenue expectations in Q1 CY2025, but sales rose 7.1% year on year to $157.2 million. On the other hand, the company’s full-year revenue guidance of $925 million at the midpoint came in 2.2% above analysts’ estimates. Its GAAP profit of $0.17 per share was 20.8% above analysts’ consensus estimates.

Telehealth company Hims & Hers Health (NYSE:HIMS) reported Q1 CY2025 results topping the market’s revenue expectations, with sales up 111% year on year to $586 million. Revenue guidance for the full year exceeded analysts’ estimates, but next quarter’s guidance of $540 million was less impressive, coming in 4.3% below expectations. Its GAAP profit of $0.20 per share was 66.4% above analysts’ consensus estimates.

Home healthcare provider Addus HomeCare (NASDAQ:ADUS) missed Wall Street’s revenue expectations in Q1 CY2025, but sales rose 20.3% year on year to $337.7 million. Its non-GAAP profit of $1.42 per share was 6.5% above analysts’ consensus estimates.

Technology real estate company Offerpad (NYSE:OPAD) fell short of the market’s revenue expectations in Q1 CY2025, with sales falling 43.7% year on year to $160.7 million. Next quarter’s revenue guidance of $175 million underwhelmed, coming in 34.1% below analysts’ estimates. Its GAAP loss of $0.55 per share was 1.9% below analysts’ consensus estimates.

Building products manufacturer JELD-WEN (NYSE:JELD) reported Q1 CY2025 results exceeding the market’s revenue expectations, but sales fell by 19.1% year on year to $776 million. Its non-GAAP loss of $0.17 per share was 10.2% above analysts’ consensus estimates.

Digital casino game platform PlayStudios (NASDAQ:MYPS) missed Wall Street’s revenue expectations in Q1 CY2025, with sales falling 19.4% year on year to $62.71 million. On the other hand, the company’s full-year revenue guidance of $260 million at the midpoint came in 1% above analysts’ estimates. Its GAAP loss of $0.02 per share was in line with analysts’ consensus estimates.

Industrials products and automation company Regal Rexnord (NYSE:RRX). reported Q1 CY2025 results exceeding the market’s revenue expectations, but sales fell by 8.4% year on year to $1.42 billion. Its non-GAAP profit of $2.15 per share was 17.7% above analysts’ consensus estimates.

Aircraft leasing company Air Lease Corporation (NYSE:AL) reported Q1 CY2025 results topping the market’s revenue expectations, with sales up 11.3% year on year to $738.3 million. Its non-GAAP profit of $1.51 per share was 28% above analysts’ consensus estimates.

Child care and education company Bright Horizons (NYSE:BFAM) met Wall Street’s revenue expectations in Q1 CY2025, with sales up 6.9% year on year to $665.5 million. The company’s outlook for the full year was close to analysts’ estimates with revenue guided to $2.89 billion at the midpoint. Its non-GAAP profit of $0.77 per share was 19.5% above analysts’ consensus estimates.

Biotech company Vertex Pharmaceuticals (NASDAQ:VRTX) missed Wall Street’s revenue expectations in Q1 CY2025 as sales rose 3% year on year to $2.77 billion. The company’s full-year revenue guidance of $11.88 billion at the midpoint came in 0.9% below analysts’ estimates. Its non-GAAP profit of $4.06 per share was 5.4% below analysts’ consensus estimates.

Building systems company Limbach (NASDAQ:LMB) reported Q1 CY2025 results exceeding the market’s revenue expectations, with sales up 11.9% year on year to $133.1 million. The company’s full-year revenue guidance of $620 million at the midpoint came in 1.4% above analysts’ estimates. Its non-GAAP profit of $1.12 per share was significantly above analysts’ consensus estimates.

Online fashion resale marketplace ThredUp (NASDAQ:TDUP) reported revenue ahead of Wall Street’s expectations in Q1 CY2025, with sales up 10.5% year on year to $71.29 million. On top of that, next quarter’s revenue guidance ($73.5 million at the midpoint) was surprisingly good and 3.7% above what analysts were expecting. Its GAAP loss of $0.04 per share was 42.9% above analysts’ consensus estimates.

Infrastructure consulting service company AECOM (NYSE:ACM) fell short of the market’s revenue expectations in Q1 CY2025, with sales falling 4.4% year on year to $3.77 billion. Its non-GAAP profit of $1.25 per share was 4.8% above analysts’ consensus estimates.

Energy and renewable energy projects company Ameresco (NYSE:AMRC) reported Q1 CY2025 results beating Wall Street’s revenue expectations, with sales up 18.2% year on year to $352.8 million. The company’s full-year revenue guidance of $1.9 billion at the midpoint came in 0.9% above analysts’ estimates. Its non-GAAP loss of $0.11 per share was 56.5% above analysts’ consensus estimates.

Civil infrastructure construction company Sterling Infrastructure (NASDAQ:STRL) beat Wall Street’s revenue expectations in Q1 CY2025, but sales fell by 2.1% year on year to $430.9 million. The company’s full-year revenue guidance of $2.1 billion at the midpoint came in 4.1% above analysts’ estimates. Its non-GAAP profit of $1.63 per share was 12.6% above analysts’ consensus estimates.

Digital media conglomerate IAC (NASDAQGS:IAC) fell short of the market’s revenue expectations in Q1 CY2025, with sales falling 38.6% year on year to $570.5 million. Its GAAP loss of $2.64 per share was 30.1% below analysts’ consensus estimates.

Diner restaurant chain Denny’s (NASDAQ:DENN) reported Q1 CY2025 results exceeding the market’s revenue expectations, with sales up 1.5% year on year to $111.6 million. Its non-GAAP profit of $0.08 per share was in line with analysts’ consensus estimates.

Video software platform Vimeo (NASDAQ:VMEO) reported Q1 CY2025 results beating Wall Street’s revenue expectations, but sales fell by 1.8% year on year to $103 million. Its GAAP loss of $0.02 per share was in line with analysts’ consensus estimates.

Data-mining and analytics company Palantir (NYSE:PLTR) reported Q1 CY2025 results exceeding the market’s revenue expectations, with sales up 39.3% year on year to $883.9 million. On top of that, next quarter’s revenue guidance ($936 million at the midpoint) was surprisingly good and 4.2% above what analysts were expecting. Its non-GAAP profit of $0.13 per share was in line with analysts’ consensus estimates.

Online insurance comparison site EverQuote (NASDAQ:EVER) reported Q1 CY2025 results topping the market’s revenue expectations, with sales up 83% year on year to $166.6 million. On top of that, next quarter’s revenue guidance ($157.5 million at the midpoint) was surprisingly good and 5.4% above what analysts were expecting. Its GAAP profit of $0.21 per share was 36.4% below analysts’ consensus estimates.